FY27 Pharmaceutical Reverse Distribution Services
See the original posting, the buyer’s contact details, and thousands more contracts like this one
Free account. Already have one? Log in
Description
SOURCES SOUGHT NOTICE PHARMACEUTICAL REVERSE DISTRIBUTION SERVICES ORLANDO VA HEALTH CARE SYSTEM (OVAHCS) Notice Type: Sources Sought (Market Research) Notice ID: 36C24827Q0037 Agency: Department of Veterans Affairs Contracting Office: Network Contracting Office 8 (NCO 8) Issuing Office Address: Orlando VA Healthcare System, 13800 Veterans Way, Orlando, FL 32827 NAICS Code: 562119 Size Standard: 250 Employees Product/Service Code: S299 Housekeeping Other Place of Performance: Multiple sites within OVAHCS (Orlando, Daytona Beach, and Viera, FL) Response Due Date: November 18, 2026, 3:00 PM 1. DISCLAIMER THIS IS A SOURCES SOUGHT NOTICE ONLY. This is not a solicitation announcement, a request for proposals, a request for quotes, or an obligation on the part of the Government to acquire any products or services. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. The Government will not pay for any information provided in response to this notice or for the Government's use of such information. All costs associated with responding to this Sources Sought are solely at the responder's expense. The purpose of this notice is to conduct market research to identify qualified sources including Service-Disabled Veteran-Owned Small Businesses (SDVOSB), Veteran-Owned Small Businesses (VOSB), and other small business categories capable of providing the services described herein. Responses will assist the Government in determining the appropriate acquisition strategy, including potential small business set-aside determinations under FAR Part 19 and 38 U.S.C. §§ 8127 8128 (VA Rule of Two). 2. BACKGROUND The Orlando VA Health Care System (OVAHCS) is required by federal regulation to remove all controlled and non-controlled substances that are expired, recalled, or otherwise determined to be unusable from active stock. These substances must be stored separately until destroyed, reverse distributed, or transferred to a DEA-license…